Clinical advances in viral-vectored influenza vaccines
Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...
Hlavní autoři: | Sebastian, S, Lambe, T |
---|---|
Médium: | Journal article |
Vydáno: |
MDPI
2018
|
Podobné jednotky
-
Clinical Advances in Viral-Vectored Influenza Vaccines
Autor: Sarah Sebastian, a další
Vydáno: (2018-05-01) -
Viral vector vaccines
Autor: McCann, N, a další
Vydáno: (2022) -
Clinical development of viral vectored vaccines against MERS-COV
Autor: Ewer, K, a další
Vydáno: (2018) -
DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
Autor: D. A. Mezhenskaia, a další
Vydáno: (2018-12-01) -
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Autor: Bissett, C, a další
Vydáno: (2024)